Conduction System Pacing With INGEVITY+
Completed
Conditions studied: Bradycardia
In brief
The study is intended to evaluate the safety and effectiveness of the Boston Scientific INGEVITY+ cardiac pacing lead when implanted in the left bundle branch area (LBBA).
Key facts
- Study ID
- NCT06014866
- Run by
- Duke University
- People needed
- 1383
- Starts
- 2023-11-13
- Expected to finish
- 2024-08-27
- Last updated by the study team
- 2025-05-23
Who can join
Age: 0 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Sarasota Memorial Health Care System — Sarasota, Florida, United States
- University of Chicago — Chicago, Illinois, United States
- Community Heart And Vascular Hospital — Indianapolis, Indiana, United States
- Essentia Health - Saint Mary's Duluth Clinic — Duluth, Minnesota, United States
- NewYork-Presbyterian Queens — Flushing, New York, United States
- Duke University — Durham, North Carolina, United States
- TriHealth Bethesda North Hospital — Cincinnati, Ohio, United States
- Houston Methodist Sugar Land Hospital — Sugar Land, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.